“Rising Emphasis on Effective Pain Management in Veterinary Care”
- A significant and accelerating trend in the global veterinary opioids market is the increased prioritization of comprehensive pain management strategies in both companion and livestock animals. Veterinarians and pet owners are becoming more aware of the importance of addressing acute and chronic pain effectively, leading to growing adoption of opioid-based therapies
- For instance, commonly used opioids such as buprenorphine, fentanyl, and tramadol are being more widely prescribed in post-surgical recovery and for managing cancer-related pain in pets. This shift is fueled by improved diagnostic capabilities and growing empathy toward animal welfare
- In veterinary surgical procedures and trauma cases, opioids remain the gold standard for providing rapid and effective analgesia. Their ability to manage moderate to severe pain, particularly in small animals such as cats and dogs, ensures their continued demand in clinics and hospitals
- The growing focus on multimodal analgesia—combining opioids with NSAIDs and local anesthetics—is also enhancing treatment outcomes, further reinforcing the use of opioids in comprehensive veterinary care protocols
- In addition, regulatory support in some developed countries allowing off-label use of human opioid drugs under veterinary supervision is expanding treatment options and enabling more personalized pain management for animals
- As the veterinary sector continues to evolve, the demand for opioid-based solutions tailored specifically for animal physiology is expected to rise, encouraging pharmaceutical companies to invest in targeted formulations and delivery systems that ensure safety, efficacy, and ease of administration
